Marker Therapeutics Inc. (MRKR)
NASDAQ: MRKR
· Real-Time Price · USD
1.63
-0.06 (-3.55%)
At close: Jun 13, 2025, 3:59 PM
1.63
0.00%
After-hours: Jun 13, 2025, 05:50 PM EDT
-3.55% (1D)
| Bid | 1.62 |
| Market Cap | 18.44M |
| Revenue (ttm) | 5.7M |
| Net Income (ttm) | -12.78M |
| EPS (ttm) | -1.19 |
| PE Ratio (ttm) | -1.37 |
| Forward PE | -0.94 |
| Analyst | Strong Buy |
| Ask | 1.85 |
| Volume | 169,185 |
| Avg. Volume (20D) | 102,839 |
| Open | 1.68 |
| Previous Close | 1.69 |
| Day's Range | 1.58 - 1.70 |
| 52-Week Range | 0.95 - 5.99 |
| Beta | 1.45 |
About MRKR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+33.33%
Marker Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-7.44%
Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.